10
Participants
Start Date
January 1, 2019
Primary Completion Date
August 30, 2022
Study Completion Date
August 30, 2022
GROUPI
10 sites treated with Free connective tissue graft (FCTG) + growth factors enhanced matrix 21 s GEM 21S + coronally advanced flap (CAF)
GROUP II
10 sites treated withCollagen membrane + GEM 21S + coronally advanced flap (CAF)
Malak Yousef Mohamed Shoukheba, Tanta
Malak Mohamed Shoukheba, Tanta
Tanta University
OTHER